Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
8/26/2024
/ Abbreviated New Drug Application (ANDA) ,
Centers for Disease Control and Prevention (CDC) ,
Drug Pricing ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Health Care Providers ,
Healthcare ,
Healthcare Facilities ,
HIV ,
HRSA ,
Medical Devices ,
Mental Health ,
Pharmaceutical Industry ,
Prescription Drugs ,
Public Health Service (PHS) ,
SAMHSA ,
Vaccinations
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
4/1/2024
/ Abbreviated New Drug Application (ANDA) ,
Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Insurance ,
Healthcare Facilities ,
Medicaid ,
Medical Devices ,
Medicare ,
Pharmaceutical Industry ,
Popular ,
Prescription Drugs
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
3/18/2024
/ Abbreviated New Drug Application (ANDA) ,
Centers for Disease Control and Prevention (CDC) ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Health Care Providers ,
Medicaid ,
Medical Devices ,
Medicare ,
Pharmaceutical Industry ,
Popular ,
Prescription Drugs ,
Telehealth
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
10/9/2023
/ Abbreviated New Drug Application (ANDA) ,
Centers for Medicare & Medicaid Services (CMS) ,
DEA ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Medicare Part D ,
National Institute of Health (NIH) ,
Nursing Homes ,
OIG ,
Pharmaceutical Industry ,
Prescription Drugs
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
6/12/2023
/ Abbreviated New Drug Application (ANDA) ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Medicare ,
Medicare Part B ,
Mental Health ,
National Institute of Health (NIH) ,
Pharmaceutical Industry ,
Popular
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
4/18/2022
/ Abbreviated New Drug Application (ANDA) ,
Advisory Board ,
CBO Report ,
Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Final Guidance ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
HRSA ,
Information Reports ,
Medical Devices ,
National Institute of Health (NIH) ,
Popular ,
Prescription Drugs ,
Proposed Rules ,
Public Meetings ,
Public Policy
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more
1/31/2022
/ Abbreviated New Drug Application (ANDA) ,
Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Federal Funding ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Mental Health Parity Rule ,
National Institute of Health (NIH) ,
Prescription Drugs ,
Provider Relief Fund ,
Regulatory Requirements ,
Vaccinations
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more
Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more
Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more
Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more
Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more
Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more
Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more